The combination of anti-GD2 mAb and MβCD therapy showed only a nonsignificant trend for tumor growth delay compared with anti-GD2 mAb treatment alone.
← all excerpts
B3GALT4 remodels the tumor microenvironment through GD2-mediated lipid raft formation and the c-met/AKT/mTOR/IRF-1 axis in neuroblastoma.
1
—
—